The Acta Group (Acta) is a global consulting firm established to control the spiraling costs and inefficiencies encountered by clients seeking approvals to market chemicals, biocides, products of nanotechnology and biotechnology, and medical device products. Acta manages products from concept to approval, utilizing the skills and experience of professionals who have worked in the specific product areas in government and industry. Our professionals are competent in the following areas: Regulatory Affairs: Professionals skilled in the requirements for approval, including the content and form of submissions, and experienced in overall project management. Toxicology: Professionals skilled in conducting literature searches, technical reviews, in-depth data reviews, study design and management, risk assessments, and exposure assessments for products regulated by EPA; USDA; FDA; ECHA; MEP, including CRC, MIIT, MOA, ICAMA and MOST. Government Affairs: Experts skilled in the workings of the regulatory agencies and adept at involving the executive and legislative branches of government, when necessary, to resolve policy issues. Acta professionals have experience in regulations affecting chemical product approvals under North American, EU, South American, Asian, and Pacific Rim regulatory programs. They regularly track significant legislative, administrative, and scientific initiatives that relate to the business of clients marketing chemicals and medical products for multiple uses.